Recent Advances in Stimuli-Responsive Doxorubicin Delivery Systems for Liver Cancer Therapy

Doxorubicin (DOX) is one of the most commonly used drugs in liver cancer. Unfortunately, the traditional chemotherapy with DOX presents many limitations, such as a systematic release of DOX, affecting both tumor tissue and healthy tissue, leading to the apparition of many side effects, multidrug res...

Descripción completa

Detalles Bibliográficos
Autores principales: Radu, Elena Ruxandra, Semenescu, Augustin, Voicu, Stefan Ioan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738136/
https://www.ncbi.nlm.nih.gov/pubmed/36501642
http://dx.doi.org/10.3390/polym14235249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738136/
https://www.ncbi.nlm.nih.gov/pubmed/36501642
http://dx.doi.org/10.3390/polym14235249

Ejemplares similares